References
- VogelmeierCFCrinerGJMartínezFJGlobal Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive SummaryArch Bronconeumol201753312814928274597
- MiravitllesMSoler-CataluñaJJCalleMSpanish COPD guidelines (GesEPOC) 2017. Pharmacological treatment of stable chronic obstructive pulmonary diseaseArch Bronconeumol20175332433528477954
- WedzichaJACalverleyPMAAlbertRKPrevention of COPD exacerbations: a European Respiratory Society/American Thoracic Society guidelineEur Respir J2017503160226528889106
- GINA reportGlobal strategy for asthma management and prevention2017 Available from: http://www.ginasthma.org/Accessed July 3, 2018
- Soler-CataluñaJJAlcázar-NavarreteBMiravitllesMThe concept of control in COPD: a new proposal for optimising therapyEur Respir J20144441072107525063243
- Soler-CataluñaJJAlcázar-NavarreteBMiravitllesMThe concept of control of COPD in clinical practiceInt J Chron Obstruct Pulmon Dis201491397140525548521
- NibberAChisholmASoler-CataluñaJJAlcázarBPriceDMiravitllesMValidating the concept of COPD control: a real-world cohort study from the United KingdomCOPD201714550451228813176
- MiravitllesMSliwinskiPRheeCKEvaluation of criteria for clinical control in a prospective, international, multicenter study of patients with COPDRespir Med201813681429501251
- BestallJCPaulEAGarrodRGarnhamRJonesPWWedzichaJAUsefulness of the medical research council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary diseaseThorax199954758158610377201
- RamonMAEsquinasCBarrechegurenMSelf-reported daily walking time in COPD: relationship with relevant clinical and functional characteristicsInt J Chron Obstruct Pulmon Dis2017121173118128458527
- JonesPWHardingGBerryPDevelopment and first validation of the COPD Assessment TestEur Respir J200934364865419720809
- KonSSCanavanJLJonesSEMinimum clinically important difference for the COPD Assessment Test: a prospective analysisLancet Respir Med20142319520324621681
- CelliBRCoteCGMarínJMThe body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary diseaseN Engl J Med2004350101005101214999112
- Soler-CataluñaJJMartínez-GarcíaMASánchezLSTorderaMPSánchezPRSevere exacerbations and BODE index: two independent risk factors for death in male COPD patientsRespir Med2009103569269919131231
- MillerMRHankinsonJBrusascoVStandardisation of spirometryEur Respir J200526231933816055882
- CoxDRRegression models and life tablesJ R Stat Soc1972B34187220
- Calle RubioMAlcázar NavarreteBSorianoJBClinical audit of COPD in outpatient respiratory clinics in Spain: the EPOCONSUL studyInt J Chron Obstruct Pulmon Dis20171241742628182155
- ThomasMKaySPikeJThe Asthma Control Test (ACT) as a predictor of GINA guideline-defined asthma control: analysis of a multinational cross-sectional surveyPrim Care Respir J2009181414919240948